Nanobiotix S.A. (EPA:NANO)
17.46
-0.50 (-2.78%)
At close: Jan 30, 2026
Nanobiotix Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 28.82 | 49.74 | 75.28 | 41.39 | 83.92 | 119.15 |
Cash & Short-Term Investments | 28.82 | 49.74 | 75.28 | 41.39 | 83.92 | 119.15 |
Cash Growth | -56.56% | -33.93% | 81.90% | -50.68% | -29.57% | 239.52% |
Accounts Receivable | 1.84 | 2.98 | 2.97 | 0.1 | - | 0.06 |
Other Receivables | 6.01 | 4.86 | 5.43 | 5.19 | 3.93 | 3.01 |
Receivables | 7.85 | 7.84 | 8.4 | 5.29 | 3.93 | 3.08 |
Prepaid Expenses | 1.93 | 3.2 | 2.56 | 2.98 | 2.21 | 2.22 |
Other Current Assets | 1.3 | 0.7 | 1.1 | 2.7 | 3 | 0.81 |
Total Current Assets | 39.89 | 61.47 | 87.34 | 52.36 | 93.06 | 125.25 |
Property, Plant & Equipment | 4.61 | 5.29 | 6.11 | 7.12 | 8.19 | 8.26 |
Other Intangible Assets | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.02 |
Other Long-Term Assets | 0.66 | 0.66 | 0.44 | 0.29 | 0.52 | 0.51 |
Total Assets | 45.17 | 67.42 | 93.9 | 59.77 | 101.77 | 134.03 |
Accounts Payable | 4.23 | 4.48 | 6.7 | 4 | 5 | 5.57 |
Accrued Expenses | 13.28 | 21.89 | 18.3 | 11.63 | 6.31 | 7.78 |
Current Portion of Long-Term Debt | 3.49 | 3.66 | 3.82 | 3.6 | 7.08 | 3.68 |
Current Portion of Leases | 1.25 | 1.26 | 1.2 | 0.96 | 1.13 | 1.2 |
Current Income Taxes Payable | 0.42 | 0.54 | 0.45 | 0.36 | 0.26 | 0.28 |
Current Unearned Revenue | 36.22 | 18.16 | 18.23 | 16.57 | 16.77 | - |
Other Current Liabilities | 4.16 | 8.94 | 1.18 | 0.82 | 0.31 | 0.53 |
Total Current Liabilities | 63.04 | 58.94 | 49.87 | 37.94 | 36.85 | 19.04 |
Long-Term Debt | 44.12 | 43.01 | 41.66 | 44.04 | 32.42 | 39.12 |
Long-Term Leases | 2.39 | 2.97 | 3.88 | 4.57 | 5.39 | 4.99 |
Pension & Post-Retirement Benefits | 0.48 | 0.43 | 0.32 | 0.27 | 0.32 | 0.41 |
Other Long-Term Liabilities | 4.11 | 27.78 | 0 | - | - | - |
Total Liabilities | 114.13 | 133.12 | 95.74 | 86.81 | 74.98 | 63.56 |
Common Stock | 1.45 | 1.42 | 1.41 | 1.05 | 1.05 | 1.03 |
Additional Paid-In Capital | 312.74 | 312.74 | 312.74 | 255.76 | 255.77 | 255.74 |
Retained Earnings | -5.38 | -68.13 | -39.7 | -57.04 | -47 | -33.59 |
Treasury Stock | -0.23 | -0.23 | -0.23 | -0.23 | -0.2 | -0.2 |
Comprehensive Income & Other | -377.53 | -311.51 | -276.07 | -226.58 | -182.82 | -152.51 |
Shareholders' Equity | -68.95 | -65.7 | -1.84 | -27.05 | 26.79 | 70.47 |
Total Liabilities & Equity | 45.17 | 67.42 | 93.9 | 59.77 | 101.77 | 134.03 |
Total Debt | 51.24 | 50.9 | 50.57 | 53.17 | 46.02 | 48.98 |
Net Cash (Debt) | -22.42 | -1.17 | 24.72 | -11.78 | 37.9 | 70.17 |
Net Cash Growth | - | - | - | - | -45.99% | - |
Net Cash Per Share | -0.47 | -0.02 | 0.67 | -0.34 | 1.09 | 2.88 |
Filing Date Shares Outstanding | 48.21 | 47.4 | 47.11 | 34.85 | 34.81 | 34.42 |
Total Common Shares Outstanding | 48.21 | 47.4 | 47.11 | 34.85 | 34.81 | 34.42 |
Working Capital | -23.15 | 2.53 | 37.47 | 14.42 | 56.22 | 106.21 |
Book Value Per Share | -1.43 | -1.39 | -0.04 | -0.78 | 0.77 | 2.05 |
Tangible Book Value | -68.97 | -65.71 | -1.85 | -27.05 | 26.79 | 70.45 |
Tangible Book Value Per Share | -1.43 | -1.39 | -0.04 | -0.78 | 0.77 | 2.05 |
Machinery | 7.18 | 7.14 | 6.73 | 6.49 | 6.5 | 6.39 |
Construction In Progress | 0.14 | 0.14 | 0.04 | 0.34 | 0.1 | 0 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.